Holen Sie sich die Stockscreener-App
2.06
0.90%
-0.0188
Handel nachbörslich:
2.05
-0.01
-0.49%
Schlusskurs vom Vortag:
$2.0788
Offen:
$2.06
24-Stunden-Volumen:
17,808
Relative Volume:
1.55
Marktkapitalisierung:
$7.52M
Einnahmen:
$11.68M
Nettoeinkommen (Verlust:
$-8.85M
KGV:
-0.4247
EPS:
-4.85
Netto-Cashflow:
$-14.61M
1W Leistung:
-5.50%
1M Leistung:
-1.90%
6M Leistung:
+5.10%
1J Leistung:
+7.85%
1-Tages-Spanne:
$2.03
$2.1728
1-Wochen-Bereich:
$2.03
$2.28
52-Wochen-Spanne:
$1.55
$2.7499
Pulmatrix Inc Stock (PULM) Company Profile
Firmenname
Pulmatrix Inc
Sektor
Branche
Telefon
(888) 355-4440
Adresse
945 CONCORD STREET, FRAMINGHAM, MA
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-02-09 | Eingeleitet | H.C. Wainwright | Buy |
Pulmatrix Inc Aktie (PULM) Neueste Nachrichten
Head-To-Head Contrast: Sage Therapeutics (NASDAQ:SAGE) and Pulmatrix (NASDAQ:PULM) - Defense World
Pulmatrix (NASDAQ:PULM) Coverage Initiated at StockNews.com - Defense World
Pulmatrix sets date for 2024 annual stockholders meeting By Investing.com - Investing.com South Africa
Pulmatrix sets date for 2024 annual stockholders meeting - Investing.com India
StockNews.com Begins Coverage on Pulmatrix (NASDAQ:PULM) - Defense World
Reviewing Pulmatrix (NASDAQ:PULM) & Emergent BioSolutions (NYSE:EBS) - Defense World
Pulmatrix, Inc. (NASDAQ:PULM) Short Interest Update - Defense World
Pulmatrix (NASDAQ:PULM) Now Covered by Analysts at StockNews.com - Defense World
Pulmatrix (NASDAQ:PULM) Receives New Coverage from Analysts at StockNews.com - Defense World
Pulmatrix (NASDAQ:PULM) Shares Pass Above Fifty Day Moving Average of $2.10 - Defense World
Pulmatrix (NASDAQ:PULM) Stock Price Crosses Above Fifty Day Moving Average of $2.08 - Defense World
Pulmatrix Second Quarter 2024 Earnings: US$1.59 loss per share (vs US$1.05 loss in 2Q 2023) - Yahoo Finance
Pulmatrix (NASDAQ:PULM) Shares Pass Above 50-Day Moving Average of $2.06 - Defense World
PULM stock touches 52-week high at $2.75 amid market fluctuations - Investing.com
StockNews.com Initiates Coverage on Pulmatrix (NASDAQ:PULM) - Defense World
PULM Stock Earnings: Pulmatrix Reported Results for Q2 2024 - InvestorPlace
Pulmatrix Announces Second Quarter 2024 Financial Results and Provides Corporate Update - Quantisnow
Pulmatrix (NASDAQ:PULM) Research Coverage Started at StockNews.com - American Banking and Market News
There Is A Reason Pulmatrix, Inc.'s (NASDAQ:PULM) Price Is Undemanding - Simply Wall St
Global Respiratory Devices Market 2024 Analysis by Top Key Players |3b Medical Inc., Pulmatrix Inc. - The NRI News
Pulmatrix (NASDAQ:PULM) Earns Hold Rating from Analysts at StockNews.com - Defense World
Pulmatrix Announces Executive Changes and New Interim CEO - TipRanks
Pulmatrix, Inc. (NASDAQ:PULM) Short Interest Up 120.0% in June - Defense World
Pulmatrix (NASDAQ:PULM) Stock Crosses Above 50 Day Moving Average of $1.92 - Defense World
Pulmatrix, Inc. (PULM) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Yahoo New Zealand News
Who Owns Most Of Pulmatrix Inc (NASDAQ:PULM)? - Yahoo Movies UK
Pulmatrix Announces Closing of $6.75 Million Registered Direct Offering - Quantisnow
Pulmatrix appoints Director Anand Varadan - Quantisnow
Pulmatrix Reports Second Quarter 2021 Financial Results and Provides Business Update - Quantisnow
Pulmatrix Announces Third Quarter 2022 Financial Results and Provides Corporate Update - Quantisnow
Pulmatrix Announces Expansion of Executive Leadership Team to Progress Clinical Pipeline - Quantisnow
Pulmatrix Announces $6.75 Million Registered Direct Offering - Quantisnow
Pulmatrix Announces Resolution of Contract Dispute with Cipla - Quantisnow
Pulmatrix Announces Second Quarter 2023 Financial Results and Provides Corporate Update - Quantisnow
Reading International (NASDAQ:RDI) Coverage Initiated at StockNews.com - Defense World
Pure Storage (NYSE:PSTG) Shares Gap Up After Analyst Upgrade - Defense World
Pulmatrix Inc (PULM)'s Ratio Roundup: Key Metrics for Trailing Twelve Months – DWinneX - The Dwinnex
MannKind expands R&D with Pulmatrix technology exchange - Investing.com India
MannKind expands R&D with Pulmatrix technology exchange By Investing.com - Investing.com Canada
Pulmatrix, Inc. (PULM) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Sport Australia
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation - PR Newswire
Amicus Therapeutics (FOLD) Reports Q3 Loss, Misses Revenue Estimates - Yahoo New Zealand News
Teacher Retirement System of Texas Has $1.58 Million Stock Holdings in Polaris Inc. (NYSE:PII) - Defense World
Pulmatrix reports progress in migraine treatment study By Investing.com - Investing.com
Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine ... - PR Newswire
Pulmatrix Publishes Study on Inhalable Migraine TreatmentTipRanks.com - TipRanks
Finanzdaten der Pulmatrix Inc-Aktie (PULM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):